Denmark’s electric car surge hits 97% of July’s new car sales for private buyers
Denmark’s shift to electric vehicles is reaching a striking new level. Nearly every new car bought by a…
Novo Nordisk anti-inflammation drug misses in heart disease study
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
Novo Nordisk sues Eli Lilly over GLP-1 drug ads it calls ‘deceptive’
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…
LifeMD, a popular telehealth firm, put profits over patient safety, ex-workers say
Highlights LifeMD, a telehealth company promoted by GLP-1 drugmaker Novo Nordisk, has urged its clinicians to see more…
Trump low-cost GLP-1 plan a likely boost for Eli Lilly, Novo Nordisk
WASHINGTON — The Trump administration’s grand bargain with drugmakers on GLP-1s was based on a simple premise: lower…
French regulator fines Novo, Lilly over weight loss ad campaigns
As competition mounts in the red-hot market for weight loss drugs, France’s medicines regulator fined Novo Nordisk approximately…
Pharmalittle: FDA push for trial transparency, Novo-OpenAI deal
Rise and shine, everyone, another busy day is on the way. And it is getting off to a…
Eli Lilly’s obesity pill approved by FDA, setting up competition with Novo Nordisk
Eli Lilly’s obesity pill was approved by the Food and Drug Administration on Wednesday, setting it up for…
Pharmalittle: Novo boosts consumer focus, FDA okays gene therapy
And so, another working week will soon draw to a close. Not a moment too soon, yes? This…
Novo Nordisk’s high-dose Wegovy approved in the U.S.
A high-dose version of Novo Nordisk’s injectable obesity drug Wegovy received U.S. approval, the company said Thursday, providing…
Novo Nordisk warned by FDA for failure to report drug side effects
Novo Nordisk received a warning from the U.S. Food and Drug Administration for failing to report suspected incidents…
Novo Nordisk, Hims reach deal to end bitter dispute over Wegovy sales
Novo Nordisk and Hims & Hers have reached a deal that, for now, appears to end their bitter…